1. Home
  2. IMNN vs AIRI Comparison

IMNN vs AIRI Comparison

Compare IMNN & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • AIRI
  • Stock Information
  • Founded
  • IMNN 1982
  • AIRI 1979
  • Country
  • IMNN United States
  • AIRI United States
  • Employees
  • IMNN N/A
  • AIRI N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • IMNN Health Care
  • AIRI Industrials
  • Exchange
  • IMNN Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • IMNN 12.9M
  • AIRI 15.4M
  • IPO Year
  • IMNN 1985
  • AIRI N/A
  • Fundamental
  • Price
  • IMNN $4.39
  • AIRI $3.20
  • Analyst Decision
  • IMNN Buy
  • AIRI
  • Analyst Count
  • IMNN 2
  • AIRI 0
  • Target Price
  • IMNN $182.61
  • AIRI N/A
  • AVG Volume (30 Days)
  • IMNN 79.1K
  • AIRI 45.1K
  • Earning Date
  • IMNN 11-05-2025
  • AIRI 11-13-2025
  • Dividend Yield
  • IMNN N/A
  • AIRI N/A
  • EPS Growth
  • IMNN N/A
  • AIRI N/A
  • EPS
  • IMNN N/A
  • AIRI N/A
  • Revenue
  • IMNN N/A
  • AIRI $52,277,000.00
  • Revenue This Year
  • IMNN N/A
  • AIRI N/A
  • Revenue Next Year
  • IMNN N/A
  • AIRI $3.53
  • P/E Ratio
  • IMNN N/A
  • AIRI N/A
  • Revenue Growth
  • IMNN N/A
  • AIRI N/A
  • 52 Week Low
  • IMNN $4.33
  • AIRI $2.80
  • 52 Week High
  • IMNN $41.22
  • AIRI $6.28
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 30.98
  • AIRI 47.09
  • Support Level
  • IMNN $4.44
  • AIRI $3.21
  • Resistance Level
  • IMNN $4.90
  • AIRI $3.33
  • Average True Range (ATR)
  • IMNN 0.32
  • AIRI 0.09
  • MACD
  • IMNN -0.04
  • AIRI -0.00
  • Stochastic Oscillator
  • IMNN 2.09
  • AIRI 33.71

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: